VIT ASX · Health Care

Vitura Health Ltd

Announcements, last 12 months
49
Price sensitive, last 12 months
13
Followed on InvestorPA
Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released Headline Actions
Notification of cessation of securities - VIT
FY26 Annual Report
Q1 FY27 Operational Update Price sensitive AI summary
Commencement of Chief Financial Officer
2026 Annual General Meeting
Doctors on Demand Update Price sensitive AI summary
Investor Webinar and presentation
FY2026 Financial Results Price sensitive AI summary
ASX Appendix 4G Corporate Governance Principles
2026 Financial Report

Sign in to see all VIT announcements.

Guidance history

7 Sep 2026 Expected $6 million revenue reduction for Doctors on Demand in FY2027
26 Aug 2026 FY2027 revenue growth expected to moderate, EBITDA improvement expected
26 Feb 2025 The company is forecasting revenue growth for FY2025 to fall slightly short of its 10% growth target, but on a normalised basis, the company remains operationally on track to meet its other full-year goals, including a 3% increase in EBITDA margin (from 5.0% in FY2024 to at least 8.0% in FY2025) and a 10% improvement in OPEX efficiency for FY2025.

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow VIT to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in